Pyridostigmine in myasthenia gravis: timing, crisis recognition and atropine

Why a cholinesterase inhibitor helps weak muscles

In myasthenia gravis, antibodies reduce the number of working acetylcholine receptors, so muscles tire with use and recover with rest. Pyridostigmine blocks the enzyme that breaks down acetylcholine, leaving more transmitter at the junction. It improves symptoms but does not change the underlying immune process, which is why many patients also need immunosuppressive treatment.

Because each dose works for only a few hours, the drug is taken several times a day. Ask whether the prescriber has timed doses around meals or periods of activity, and plan care so that tasks needing strength, such as eating, fall within that window. Extended-release tablets are swallowed whole and not crushed or chewed; if swallowing is impaired, report it, since another route may be needed.

Expected muscarinic effects versus warning signs

Extra acetylcholine also stimulates muscarinic receptors, causing abdominal cramps, diarrhoea, nausea, increased saliva, sweating, urinary urgency and muscle twitching. These are common and may be managed with medicines the prescriber orders, including oral atropine for gastrointestinal effects. Pyridostigmine is used cautiously in asthma because it can increase bronchial secretions and narrowing.

Warning signs are different. Report increasing weakness of the face, throat or limbs, difficulty swallowing or clearing secretions, a weak cough, slurred speech or breathlessness. Ask about recent infection, surgery or new medicines, because aminoglycosides, magnesium sulfate, quinine, procainamide and calcium channel blockers can precipitate worsening myasthenia.

Myasthenic crisis or cholinergic crisis

Myasthenic crisis is severe generalised or respiratory muscle weakness from worsening disease, often triggered by infection. It suggests too little effective treatment. Cholinergic crisis results from too much cholinesterase inhibitor and also causes weakness, but severe cases add fasciculations, increased tears and saliva, and diarrhoea. Mild cases can be hard to tell apart from worsening myasthenia.

The distinction matters because the treatments are opposite: more drug may help myasthenic crisis but worsens cholinergic crisis, which calls for withdrawal of the drug and prompt atropine. The nurse does not decide alone or give extra doses on a hunch. Keep atropine available and escalate any crisis picture early, since respiratory failure can develop quickly.

Respiratory monitoring and teaching

Bedside measures such as forced vital capacity help detect impending respiratory failure. Trend them with respiratory rate, oxygen saturation, voice strength, cough and swallow. Saturation can stay acceptable until late, so falling vital capacity or a weakening cough is an earlier cue. Keep suction and airway equipment ready and position the patient upright.

Teach patients to take doses on time, keep a written schedule and record of symptoms, and not to double up after missing a dose without advice. Encourage them to tell every prescriber, dentist and pharmacist about the diagnosis before new medicines are started. Explain which signs, such as trouble breathing or swallowing, need emergency care rather than a routine call.

Admission to hospital is a common point of error. Doses can be delayed by fasting orders, procedures or transfers, and a missed dose may leave a patient too weak to swallow or cough safely. Flag the timing on the medication chart, ask the patient what their usual schedule is, and report any delay so the prescriber can arrange an alternative before strength falls.

Worked exam-style scenario

Imagine a hypothetical patient with myasthenia gravis who took extra pyridostigmine doses at home for fatigue and now has generalised weakness, drooling, watery eyes, muscle twitching and diarrhoea. Options include giving the next scheduled dose early, encouraging rest, offering an antidiarrhoeal, or withholding further doses, assessing breathing and escalating with atropine available.

Withholding and escalating is the strongest answer because extra intake with fasciculations, secretions and diarrhoea points toward cholinergic crisis. An early dose worsens it, and rest or an antidiarrhoeal miss the danger. Change the stem to fever, dysphagia and weakness without secretions after a chest infection, and myasthenic crisis becomes the likely concern, still with urgent respiratory assessment.

Sources and further reading

DailyMed: MESTINON (pyridostigmine bromide) prescribing information. Cholinergic crisis from overdosage, difficulty distinguishing it from myasthenic crisis, drug withdrawal and atropine use, and asthma caution.

MSD Manual Professional: Myasthenia gravis. Crisis definitions and distinguishing features, forced vital capacity monitoring, precipitating drugs and atropine for GI effects.

NHS: Myasthenia gravis treatment. Pyridostigmine as first-line medicine, short duration of effect requiring several daily doses and common side effects.